Mabylon AG clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Minor: Pharmacodynamic Effects of MY006 in Healthy Volunteers and · Peanut Allergy Enrollment increased: 48 → 56 participants
- Notable: Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2030
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 1 |
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Get alerts when Mabylon AG's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.